Organization · Type 2 NPI
Veincare Solutions LLC
Interventional Pain Medicine Physician · Riverdale, NJ
Practice location
18 Newark Pompton Tpke
Riverdale, NJ 07457-1141
Mailing address
576 Valley Rd # 207
Wayne, NJ 07470-3526
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Interventional Pain Medicine Physician Primary | 208VP0014X | None listed |
Interventional Pain Medicine Physician: Interventional Pain Medicine is the discipline of medicine devoted to the diagnosis and treatment of pain and related disorders principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment.
15 other providers at this address
- Advanced Sports Medicine and PTPhysical Therapist Riverdale, NJ NPI 1528155561
- Advanced Therapy and ChiropracticChiropractor Riverdale, NJ NPI 1699431395
- Kids Therapy CenterPediatric Physical Therapist Riverdale, NJ NPI 1013121854
- Open Mri Centers of New Jersey, LLCMagnetic Resonance Imaging (MRI) Clinic/Center Riverdale, NJ NPI 1376630319
- Regional Cancer Care Associates LLCHematology & Oncology Physician Riverdale, NJ NPI 1578021853
- Andrew M. Bernstein, DOHematology & Oncology Physician Riverdale, NJ NPI 1669490975
- Christine Carmean Foss, DCChiropractor Riverdale, NJ NPI 1962590323
- Danielle Colaprico, OTR/LSpecialist Riverdale, NJ NPI 1417368572
- Giselle Foss, DCChiropractor Riverdale, NJ NPI 1770175069
- Janelle Marie Giresi, DPTPhysical Therapist Riverdale, NJ NPI 1902114333
- Kara McConnellNutritionist Riverdale, NJ NPI 1336310200
- Kevin Pavlak, DCChiropractor Riverdale, NJ NPI 1831697697
Other interventional pain medicine physician providers in Riverdale
About NPI 1558119651
Veincare Solutions LLC's National Provider Identifier is 1558119651, issued on May 13, 2024. The primary taxonomy on file is Interventional Pain Medicine Physician (208VP0014X), and the practice location is in Riverdale, NJ. The record was last updated on Jan 20, 2025.